David A. Jenkins - Mar 23, 2023 Form 4 Insider Report for Ra Medical Systems, Inc. (RMED)

Role
Ex. Chairman of the Board, Director
Signature
/s/ David Jenkins
Stock symbol
RMED
Transactions as of
Mar 23, 2023
Transactions value $
$0
Form type
4
Date filed
3/27/2023, 05:18 PM
Previous filing
Jan 11, 2023
Next filing
Jan 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMED Common Stock Conversion of derivative security $0 +278K $0.00 278K Mar 23, 2023 Direct F1
transaction RMED Common Stock Conversion of derivative security $0 +710K $0.00 710K Mar 23, 2023 See footnote F1, F2
transaction RMED Common Stock Conversion of derivative security $0 +2.26K $0.00 2.26K Mar 23, 2023 See footnote F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMED Series X Convertible Preferred Stock Conversion of derivative security $0 -278 -10.8% $0.00 2.29K Mar 23, 2023 Common Stock 2.29M $0.00 Direct F4, F5
transaction RMED Series X Convertible Preferred Stock Conversion of derivative security $0 -710 -10.8% $0.00 5.86K Mar 23, 2023 Common Stock 5.86M $0.00 See footnote F2, F4, F5
transaction RMED Series X Convertible Preferred Stock Conversion of derivative security $0 -2.26 -10.8% $0.00 18.7 Mar 23, 2023 Common Stock 18.7K $0.00 See footnote F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval.
F2 Shares held by a partnership of which the reporting person is the managing member of the managing partner.
F3 Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee.
F4 Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American.
F5 Series X Convertible Preferred Stock has no expiration date.